文献速递肝病

PNPLA3基因rs738409:G纯合子与严重酒精性肝炎发作后死亡率增加相关

Homozygosity for rs738409:G in PNPLA3 is associated with increased mortality following an episode of severe alcoholic hepatitis.
PubMed 文献 · J Hepatol · 2017-02-02

该研究基于英国STOPAH试验的898例严重酒精性肝炎患者和1188例无肝损伤的酒精依赖对照,发现rs738409:G频率在病例组显著高于对照组(29.5% vs 18.9%,OR 1.80)。rs738409:G与28天死亡率无关,但纯合子与90至450天期间死亡率升高相关(HR 1.69)。

要点

  • rs738409:G在严重酒精性肝炎患者中的频率显著高于无肝损伤的酒精依赖对照(29.5% vs 18.9%)。
  • rs738409:G与28天死亡率无关联。
  • rs738409:G纯合子与90至450天期间死亡率升高相关(HR 1.69,95%CI 1.02-2.81,p=0.04)。

核心结论

  • PNPLA3基因rs738409:G纯合子与严重酒精性肝炎患者中期死亡率显著增加相关。
  • 作者认为,在考虑这些患者的治疗方案时,可将rs738409基因型纳入考量。

研究设计与样本

  • 研究对898例严重酒精性肝炎患者(通过英国STOPAH试验招募)和1188例无肝损伤的白人英国/爱尔兰酒精依赖对照(通过伦敦大学学院招募)进行了基因分型。
  • 对存活≥90天的病例,将后续饮酒行为分类为戒酒或饮酒,并探讨rs738409基因型、饮酒行为与生存之间的关系。

主要发现

  • rs738409:G在病例组中的频率显著高于对照组(29.5% vs 18.9%;p=2.15×10-15;OR 1.80,95%CI 1.55-2.08)。
  • 病例在第28天、90天和450天的死亡率分别为16%、25%和41%。
  • rs738409:G与28天死亡率无关联。
  • 在90至450天期间,随后恢复饮酒的存活者死亡率更高(HR 2.77,95%CI 1.79-4.29;p<0.0001)。
  • 在90至450天期间,rs738409:G纯合子个体的死亡率更高(HR 1.69,95%CI 1.02-2.81,p=0.04)。

临床怎么用

  • 作者认为,在考虑这些患者的治疗方案时,可将rs738409基因型纳入考量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Carriage of rs738409:G in PNPLA3 is associated with an increased risk of developing alcohol-related cirrhosis and has a significant negative effect on survival. Short-term mortality in patients with severe alcoholic hepatitis is high; drinking behaviour is a major determinant of outcome in survivors. The aim of this study was to determine whether carriage of rs738409:G has an additional detrimental effect on survival in this patient group. METHODS: Genotyping was undertaken in 898 cases with severe alcoholic hepatitis, recruited through the UK Steroids or Pentoxifylline for Alcoholic Hepatitis (STOPAH) trial, and 1188 White British/Irish alcohol dependent controls with no liver injury, recruited via University College London. Subsequent drinking behaviour was classified, in cases surviving ≥90days, as abstinent or drinking. The relationship between rs738409 genotype, drinking behaviour and survival was explored. RESULTS: The frequency of rs738409:G was significantly higher in cases than controls (29.5% vs. 18.9%; p=2.15×10-15; odds ratio 1.80 [95% confidence interval (CI) 1.55-2.08]). Case-mortality at days 28, 90 and 450 was 16%, 25% and 41% respectively. There was no association between rs738409:G and 28-day mortality. Mortality in the 90 to 450-day period was higher in survivors who subsequently resumed drinking (hazard ratio [HR] 2.77, 95% CI 1.79-4.29; p<0.0001) and in individuals homozygous for rs738409:G (HR 1.69, 95% CI 1.02-2.81, p=0.04). CONCLUSION: Homozygosity for rs738409:G in PNPLA3 confers significant additional risk of medium-term mortality in patients with severe alcoholic hepatitis. Rs738409 genotype may be taken into account when considering treatment options for these patients. LAY SUMMARY: Individuals misusing alcohol who carry a particular variant of the gene PNPLA3 are more at risk of developing severe alcoholic hepatitis, a condition with a poor chance of survival. The longer-term outcome in people with this condition who survive the initial illness is strongly influenced by their ability to remain abstinent from alcohol. However, carriers of this gene variant are less likely to survive even if they are able to stop drinking completely. Knowing if someone carries this gene variant could influence the way in which they are managed. Clinical trial numbers: EudraCT reference number: 2009-013897-42; ISRCTN reference number: ISRCTN88782125. CLINICAL TRIAL NUMBERS: EudraCT reference number: 2009-013897-42; ISRCTN reference number: ISRCTN88782125.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Atkinson SR, Way MJ, McQuillin A, et al. Homozygosity for rs738409:G in PNPLA3 is associated with increased mortality following an episode of severe alcoholic hepatitis. J Hepatol. 2017. PMID: 28161471. doi:10.1016/j.jhep.2017.01.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。